A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery
- PMID: 10094341
- PMCID: PMC7056106
A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery
Abstract
Background and purpose: Osmotic disruption of the blood-brain barrier (BBB) provides a method for transvascular delivery of therapeutic agents to the brain. The apparent global delivery of viral-sized iron oxide particles to the rat brain after BBB opening as seen on MR images was compared with the cellular and subcellular location and distribution of the particles.
Methods: Two dextran-coated superparamagnetic monocrystalline iron oxide nanoparticle contrast agents, MION and Feridex, were administered intraarterially in rats at 10 mg Fe/kg immediately after osmotic opening of the BBB with hyperosmolar mannitol. After 2 to 24 hours, iron distribution in the brain was evaluated first with MR imaging then by histochemical analysis and electron microscopy to assess perivascular and intracellular distribution.
Results: After BBB opening, MR images showed enhancement throughout the disrupted hemisphere for both Feridex and MION. Feridex histochemical staining was found in capillaries of the disrupted hemisphere. Electron microscopy showed that the Feridex particles passed the capillary endothelial cells but did not cross beyond the basement membrane. In contrast, after MION delivery, iron histochemistry was detected within cell bodies in the disrupted hemisphere, and the electron-dense MION core was detected intracellularly and extracellularly in the neuropil.
Conclusion: MR images showing homogeneous delivery to the brain at the macroscopic level did not indicate delivery at the microscopic level. These data support the presence of a physiological barrier at the basal lamina, analogous to the podocyte in the kidney, distal to the anatomic (tight junction) BBB, which may limit the distribution of some proteins and viral particles after transvascular delivery to the brain.
Figures
Comment in
-
Assessing effective transvascular particle delivery to the brain parenchyma: a challenge to neuroradiology.AJNR Am J Neuroradiol. 1999 Feb;20(2):186. AJNR Am J Neuroradiol. 1999. PMID: 10094333 Free PMC article. No abstract available.
-
Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide.AJNR Am J Neuroradiol. 2000 Oct;21(9):1767-8. AJNR Am J Neuroradiol. 2000. PMID: 11039364 No abstract available.
References
-
- Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998;42:1083-1100 - PubMed
-
- Pardridge WM. Drug delivery to the brain. J Cereb Blood Flow Metab 1997;17:713-731 - PubMed
-
- Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E. Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol 1973;152:317-326 - PubMed
-
- Rapoport SI, Robinson PJ. Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann N Y Acad Sci 1986;481:250-267 - PubMed
-
- Dahlborg SA, Henner WD, Crossen JR, et al. Non-AIDS primary CNS lymphoma: the first example of durable response in a primary brain tumor using enhance chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 1996;2:166-174 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical